The Quantellect read.As of Nov 19, 2026, 5 active firms cover Ambev SA ADR: 0 rate it Buy or better, 3 sit at Neutral, and 2 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $2.88 to $3.50, so the covering firms are broadly aligned. The average target of $3.14 sits 16% above the current $2.71. Sentiment has cooled somewhat, with Sell ratings rising from 1 to 2 over recent months. On the fundamentals, the Street sees revenue growth near 4% this year and 5% next, consensus EPS building from about $0.05 next quarter toward $0.20 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Neutral
Strong Buy00%
Buy00%
Neutral360%
Sell240%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$3.14
+16.1% upside
Average target across 4 active firms as of Nov 19, 2026 vs $2.71 current
Highest Target$3.50
Average Target$3.14
Lowest Target$2.88
Detailed analyst forecasts for ABEV
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 0 of 5 active firms rate ABEV a Buy (3 Neutral, 2 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ABEV EPS & revenue forecast
EPS · NEXT QUARTER
$0.05
Range $0.05 – $0.05 · 1 analysts · +3% YoY
Next period, 1 analysts expect Ambev SA ADR to earn $0.05 a share (range $0.05 – $0.05), versus $0.05 a year earlier. Full-year consensus is $0.20, growing to $0.20 the year after.
REVENUE · NEXT QUARTER
$23.5B
Range $23.5B – $23.5B · 1 analysts · +7% YoY
Revenue is expected to reach $23.5B (range $23.5B – $23.5B), +7.0% year-over-year. Full-year consensus is $90.3B, rising to $95.0B next year.
Top analysts covering Ambev SA ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ABEV.
#1
Benjamin Theurer
Barclays · Rank #209
Neutral
$3.50+29.2% to target
Overall win rate
45%
+ Follow
#2
RA
Rodrigo Alcantara
UBS
Sell
$2.85+5.2% to target
Coverage
—
+ Follow
#3
IS
Isabella Simonato
B of A Securities
Sell
$3.30+21.8% to target
Coverage
—
+ Follow
#4
NS
Nadine Sarwat
Bernstein
Neutral
$2.88+6.3% to target
Coverage
—
+ Follow
#5
FU
Felipe Ucros
Scotiabank
Neutral
No targeton ABEV
Coverage
—
+ Follow
ABEV stock forecast FAQ
What is ABEV's average 12-month price target?+
The 4 active firms with a live target average $3.14 for Ambev SA ADR over the next 12 months, ranging from a $3.50 high to a $2.88 low, as of Nov 19, 2026.
Is ABEV stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 5 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 3 rate it Neutral, and 2 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ABEV?+
The Street-high target is $3.50 (Barclays), and the Street-low is $2.88 (Bernstein). The average of all 4 active-firm targets is $3.14.
How many active Wall Street firms cover ABEV?+
5 active firms have a recognized rating on Ambev SA ADR as of Nov 19, 2026, and 4 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ABEV?+
Among analysts who currently cover ABEV, Benjamin Theurer of Barclays has the strongest overall Quantellect track record (Rank #209). Their current call is Neutral with a $3.50 target.
What is Ambev SA ADR's projected EPS for next quarter?+
The consensus estimate is $0.05 per share (range $0.05 – $0.05) across 1 analysts. Full-year EPS is projected at $0.20, rising to $0.20 the following year.
How much revenue is Ambev SA ADR expected to report next quarter?+
Consensus revenue is $23.5B (range $23.5B – $23.5B). Full-year revenue is projected at $90.3B, growing to $95.0B next year.
Have analysts been upgrading or downgrading ABEV lately?+
As of Nov 19, 2026, 0 of 5 active firms rate ABEV a Buy (3 Neutral, 2 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ABEV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.